REMEDY : BNSSG referral pathways & Joint Formulary


Home > Formulary : Paediatric > Paediatric Chapters > 2. Cardiovascular system >

BNSSG Paediatric Joint Formulary

2.2 Bleeding disorders

Last edited: 03-06-2025

First line drugs Second line drugs Specialist drugs Secondary care drugs

2.2 Bleeding disorders

Secondary Care to maintain responsibility for monitoring amber specialist initiated drugs in the cardiovascular section of the Paediatric formulary. A clear management plan detailed in the clinic letter is required to support primary care prescribing. GP Practices should ensure a plan is in place before taking over prescribing responsibility

Antifibrinolytic Drugs and Haemostatics

Tranexamic Acid (TLS Green)

 

2.2 Subarachnoid haemorrhage

Nimodipine (TLS Red)

2.3 Haemophilia

Haemophilia B

Marstacimab (TLS Red)

  • NHSE SSC 2836 Marstacimab for treating severe haemophilia B in people 12 years and over without anti-factor antibodies